T1	Fact 15 137	The stress response, such as the inflammatory response, plays a key role in regulating IL-10 expression (Li et al., 2008).
A1	Source T1 Non-integral_information_led_citation
T2	KT_cue 15 35;71 76	The stress response, plays
R1	Cue Arg1:T2 Arg2:T1	
T3	Source_cue 119 137	(Li et al., 2008).
R2	Cue Arg1:T3 Arg2:T1	
T4	Fact 138 440	Inflammation of the central nervous system in particular releases  IL-1 following trauma, neurosurgery, or an increase of inter-brain pressure, this then activates  the stress axis, triggering the release of catecholamines that up-regulate IL-10 production in macrophages (Woichiechowsky et al., 1998).
A2	Source T4 Non-integral_information_led_citation
T5	KT_cue 138 203	Inflammation of the central nervous system in particular releases
R3	Cue Arg1:T5 Arg2:T4	
T6	Source_cue 410 438	(Woichiechowsky et al., 1998
R4	Cue Arg1:T6 Arg2:T4	
T7	Observation 441 572	IL-10 has been reported to be co-released  with  IL-1 with the ability to eventually inhibit the production of both IL-1 and TNF-a.
A3	Source T7 Averred
T8	KT_cue 441 464	IL-10 has been reported
R5	Cue Arg1:T8 Arg2:T7	
T9	Observation 575 688	study carried out by Knoblach et al (1998) found that traumatic brain injury was improved with treatment of IL-10
A4	Source T9 Integral_citation
A5	Verb_noun T9 Certainty
T10	Source_cue 573 617	A study carried out by Knoblach et al (1998)
R6	Cue Arg1:T10 Arg2:T9	
T11	KT_cue 573 623	A study carried out by Knoblach et al (1998) found
R7	Cue Arg1:T11 Arg2:T9	
T12	Verb_cue 573 628	A study carried out by Knoblach et al (1998) found that
R8	Cue Arg1:T12 Arg2:T9	
T13	Analysis 689 752	and this was associated with decreased IL-1 in the hippocampus.
A6	Source T13 Integral_citation
A7	Certainty_Level T13 L2
T14	KT_cue 693 717	this was associated with
R9	Cue Arg1:T14 Arg2:T13	
T15	CL_cue 693 717	this was associated with
R10	Cue Arg1:T15 Arg2:T13	
T19	Investigation 940 1108	During this PhD study the  main aim is to identify the signalling pathway IL-10 takes to reduce the inflammatory cytokines in the heart during pathological hypertrophy.
A10	Source T19 Self_other
T20	Source_cue 940 961	During this PhD study
R13	Cue Arg1:T20 Arg2:T19	
T21	KT_cue 962 990	the  main aim is to identify
R14	Cue Arg1:T21 Arg2:T19	
T22	Observation 1110 1208	Other studies confirmed the importance of the presence of the IL-10 cytokines during inflammation.
A11	Source T22 General_reference
T23	Source_cue 1110 1123	Other studies
R15	Cue Arg1:T23 Arg2:T22	
T24	KT_cue 1110 1133	Other studies confirmed
R16	Cue Arg1:T24 Arg2:T22	
T25	Observation 1209 1363	Kuhn et al (1993) found that IL-10 deficient mice developed lethal inflammation of the intestines which was inhibited by systemic administration of IL-10.
A12	Source T25 Integral_citation
A13	Verb_noun T25 Certainty
T26	Source_cue 1209 1226	Kuhn et al (1993)
R17	Cue Arg1:T26 Arg2:T25	
T27	KT_cue 1209 1232	Kuhn et al (1993) found
R18	Cue Arg1:T27 Arg2:T25	
T28	Verb_cue 1209 1237	Kuhn et al (1993) found that
R19	Cue Arg1:T28 Arg2:T25	
T34	Observation 1457 1599	however there was reduced inflammation in the intestines following administration of IL-10 supporting the previous study by Kuhn et al (1993).
A17	Source T34 Integral_citation
A18	Multiple_sources T34
T35	KT_cue 1465 1474	there was
R24	Cue Arg1:T35 Arg2:T34	
T43	Fact 1777 1964	The Th1 response is the activation of cytokines that produce the pro- inflammatory responses responsible for killing intracellular parasites and for perpetuating the autoimmune responses.
A24	Source T43 Averred
T44	KT_cue 1777 1796	The Th1 response is
R30	Cue Arg1:T44 Arg2:T43	
T54	Observation 2339 2463	IL-10 has also been shown to act as an antagonist to TNF-a by inhibiting TNF-a induced oxidative stress (Kaur et al., 2006).
A32	Source T54 Non-integral_information_led_citation
T55	KT_cue 2339 2364	IL-10 has also been shown
R38	Cue Arg1:T55 Arg2:T54	
T56	Source_cue 2443 2463	(Kaur et al., 2006).
R39	Cue Arg1:T56 Arg2:T54	
T57	Fact 2464 2611	The systemic release of TNF-a induces  IL-10  via  a  negative feedback mechanism which involves the dependent NF-?B pathway (Meisel et al., 1996).
A33	Source T57 Non-integral_information_led_citation
T58	KT_cue 2464 2501	The systemic release of TNF-a induces
R40	Cue Arg1:T58 Arg2:T57	
T59	Source_cue 2589 2611	(Meisel et al., 1996).
R41	Cue Arg1:T59 Arg2:T57	
T60	Observation 2612 2729	Dhingra et al (2007) found that TNF-a was upregulated via p38  phosphorylation  resulting in cardiomyocyte apoptosis.
A34	Source T60 Integral_citation
A35	Verb_noun T60 Certainty
T61	Source_cue 2612 2632	Dhingra et al (2007)
R42	Cue Arg1:T61 Arg2:T60	
T62	KT_cue 2612 2638	Dhingra et al (2007) found
R43	Cue Arg1:T62 Arg2:T60	
T63	Verb_cue 2612 2643	Dhingra et al (2007) found that
R44	Cue Arg1:T63 Arg2:T60	
T69	Observation 2912 3016	IL-10 prevented this effect of TNF-a by the  upregulation  of extracellular signal-regulated kinase ERK.
A39	Citation_length T69 Extended
A40	Source T69 Integral_citation
A41	Neg_CL T69
T70	KT_cue 2912 2927	IL-10 prevented
R49	Cue Arg1:T70 Arg2:T69	
T71	Fact 3017 3076	However, how IL-10 supresses  TNF-a  still remains unknown.
A42	Source T71 Averred
A43	Neg_CL T71
T72	KT_cue 3026 3076	how IL-10 supresses  TNF-a  still remains unknown.
R50	Cue Arg1:T72 Arg2:T71	
T73	Investigation 3077 3222	This PhD study aims to investigate the target site of IL-10 signalling which produces a protective role by inhibiting the inflammatory cytokines.
A44	Source T73 Self_other
T74	KT_cue 3077 3099	This PhD study aims to
R51	Cue Arg1:T74 Arg2:T73	
T75	Source_cue 3077 3091	This PhD study
R52	Cue Arg1:T75 Arg2:T73	
T79	Analysis 3513 3718	IL-10 has  been  described as  having protective properties in the development of atherosclerosis by delaying the progress of the  disease  by  significantly  decreasing  cell  death (Mallat et al., 1999).
A46	Source T79 Non-integral_information_led_citation
T80	KT_cue 3513 3542	IL-10 has  been  described as
R55	Cue Arg1:T80 Arg2:T79	
A47	Certainty_Level T79 L3
T81	CL_cue 3513 3542	IL-10 has  been  described as
R56	Cue Arg1:T81 Arg2:T79	
T82	Source_cue 3696 3718	(Mallat et al., 1999).
R57	Cue Arg1:T82 Arg2:T79	
T83	Investigation 3719 3826	De Waal Malefyt et al (1991) and Romagnani (1995) carried out an investigation of IL-10 on the immune cells
A48	Source T83 Integral_citation
A49	Multiple_sources T83
T84	Source_cue 3719 3768	De Waal Malefyt et al (1991) and Romagnani (1995)
R58	Cue Arg1:T84 Arg2:T83	
T85	KT_cue 3719 3780	De Waal Malefyt et al (1991) and Romagnani (1995) carried out
R59	Cue Arg1:T85 Arg2:T83	
T93	Observation 4251 4441	A similar study by Verma et al (2001) also found that IL-10 suppresses the inflammatory response and improves left ventricular functioning and remodelling during acute myocardial infarction.
A55	Source T93 Integral_citation
A56	Verb_noun T93 Certainty
T94	Source_cue 4251 4288	A similar study by Verma et al (2001)
R65	Cue Arg1:T94 Arg2:T93	
T95	KT_cue 4251 4299	A similar study by Verma et al (2001) also found
R66	Cue Arg1:T95 Arg2:T93	
T96	Verb_cue 4251 4304	A similar study by Verma et al (2001) also found that
R67	Cue Arg1:T96 Arg2:T93	
T97	Observation 4442 4651	IL-10 suppressed the inflammatory response via the suppression of HuR/matrix metalloproteinase-9 and by enhancing density through activation of the signal transducer and activator  of  transcription 3 (STAT3).
A57	Citation_length T97 Extended
A58	Source T97 Integral_citation
T98	KT_cue 4442 4458	IL-10 suppressed
R68	Cue Arg1:T98 Arg2:T97	
T103	Investigation 4756 4888	Researchers also investigated the effects of treatment of IL-10 using either overexpression of IL-10 or recombinant IL-10 (rhIL-10).
A62	Source T103 General_reference
T104	KT_cue 4756 4785	Researchers also investigated
R72	Cue Arg1:T104 Arg2:T103	
T105	Source_cue 4756 4785	Researchers also investigated
R73	Cue Arg1:T105 Arg2:T103	
T106	Observation 4889 4987	Interestingly Nishio et al (1990) found that treatment with rhIL-10 attenuated myocardial lesions.
A63	Source T106 Integral_citation
A64	Verb_noun T106 Certainty
T107	Source_cue 4903 4922	Nishio et al (1990)
R74	Cue Arg1:T107 Arg2:T106	
T108	KT_cue 4903 4928	Nishio et al (1990) found
R75	Cue Arg1:T108 Arg2:T106	
T109	Verb_cue 4903 4933	Nishio et al (1990) found that
R76	Cue Arg1:T109 Arg2:T106	
T110	Observation 4988 5111	In addition Verma et al (2001) found that systemic rhIL- 10 administration significantly improved left ventricular function
A65	Source T110 Integral_citation
A66	Verb_noun T110 Certainty
T111	KT_cue 5000 5024	Verma et al (2001) found
R77	Cue Arg1:T111 Arg2:T110	
T112	Verb_cue 5000 5029	Verma et al (2001) found that
R78	Cue Arg1:T112 Arg2:T110	
T113	Source_cue 5000 5018;5208 5227;5233 5254	Verma et al (2001) Powrie et al (1993) Herfarth et al (1996)
R79	Cue Arg1:T113 Arg2:T110	
T114	Observation 5112 5329	and not only inhibited but also reversed hypertrophic induced cardiac remodelling contradicting Powrie et al (1993) and  Herfarth et al (1996) study that IL-10 is ineffective at reversing any established inflammation.
A67	Source T114 Integral_citation
A68	Neg_CL T114
A69	Multiple_sources T114
A70	Multiple_sources T110
T115	KT_cue 5116 5134	not only inhibited
R80	Cue Arg1:T115 Arg2:T114	
T120	Observation 5466 5632	In further support Stumpf et al (2008) found that treatment with rhIL-10 significantly improves left ventricular function in rats after induced myocardial infarction.
A77	Source T120 Integral_citation
A78	Verb_noun T120 Certainty
T121	Source_cue 5485 5504	Stumpf et al (2008)
R84	Cue Arg1:T121 Arg2:T120	
T122	KT_cue 5485 5510	Stumpf et al (2008) found
R85	Cue Arg1:T122 Arg2:T120	
T123	Verb_cue 5485 5515	Stumpf et al (2008) found that
R86	Cue Arg1:T123 Arg2:T120	
T124	Analysis 5633 5716	The data demonstrated a decrease in TNF-a with administration of recombinant IL-10.
A79	Source T124 Integral_citation
A81	Citation_length T124 Extended
A82	Certainty_Level T124 L4
T125	KT_cue 5633 5654	The data demonstrated
R87	Cue Arg1:T125 Arg2:T124	
T126	CL_cue 5633 5654	The data demonstrated
R88	Cue Arg1:T126 Arg2:T124	
T127	Analysis 5717 5889	This effect was associated with a decrease in the inflammatory cytokines TNF-a and IL-6, a decrease of the chemokines and a reduction of myocardial macrophage infiltration.
A80	Source T127 Integral_citation
A83	Citation_length T127 Extended
A84	Certainty_Level T127 L2
T128	KT_cue 5717 5748	This effect was associated with
R89	Cue Arg1:T128 Arg2:T127	
T129	CL_cue 5717 5748	This effect was associated with
R90	Cue Arg1:T129 Arg2:T127	
T135	Observation 6146 6182	IL-10  deficiency  has been observed
A88	Source T135 Non-integral_information_led_citation
T136	KT_cue 6146 6182	IL-10  deficiency  has been observed
R95	Cue Arg1:T136 Arg2:T135	
T137	Analysis 6183 6356	and is regarded to have pathophysiological  relevance  in  certain  inflammatory disorders that are characterised by a type 1 cytokine  such  as  psoriasis (Romagnani 1995).
A89	Source T137 Non-integral_information_led_citation
A90	Certainty_Level T137 L2
T138	KT_cue 6187 6201	is regarded to
R96	Cue Arg1:T138 Arg2:T137	
T139	CL_cue 6187 6201	is regarded to
R97	Cue Arg1:T139 Arg2:T137	
T140	Source_cue 6339 6356	(Romagnani 1995).
R98	Cue Arg1:T140 Arg2:T137	
T141	Observation 6358 6499	Other studies that investigated the effects of the overexpression of IL-10 found negative findings due to the dampening of the immune system.
A91	Source T141 General_reference
A92	Neg_CL T141
T142	Source_cue 6358 6371	Other studies
R99	Cue Arg1:T142 Arg2:T141	
T143	KT_cue 6358 6389	Other studies that investigated
R100	Cue Arg1:T143 Arg2:T141	
T76	Fact 3300 3383	In relation to existing knowledge regarding IL-10 as an anti-inflammatory cytokine,
A45	Source T76 General_reference
T77	KT_cue 3300 3333	In relation to existing knowledge
R53	Cue Arg1:T77 Arg2:T76	
T78	Investigation 3384 3512	researchers have investigated the anti-inflammatory cytokine as  a  possible target  to counteract the  effects of inflammation.
A106	Source T78 General_reference
T162	KT_cue 3384 3413	researchers have investigated
R54	Cue Arg1:T162 Arg2:T78	
T163	Source_cue 3384 3395	researchers
R114	Cue Arg1:T163 Arg2:T78	
T99	Analysis 4652 4686	These studies all corroborate that
A59	Verb_noun T99 Attitude
A60	Source T99 Hidden
A61	Certainty_Level T99 L4
T100	KT_cue 4652 4681	These studies all corroborate
R69	Cue Arg1:T100 Arg2:T99	
T101	CL_cue 4652 4681	These studies all corroborate
R70	Cue Arg1:T101 Arg2:T99	
T102	Verb_cue 4652 4686	These studies all corroborate that
R71	Cue Arg1:T102 Arg2:T99	
T164	Fact 4687 4754	IL-10 has the ability to inhibit inflammation during heart failure.
A99	Source T164 Averred
T165	KT_cue 4687 4696	IL-10 has
R115	Cue Arg1:T165 Arg2:T164	
T29	Analysis 1364 1407	Barbara et al (2000) also demonstrated that
A14	Verb_noun T29 Certainty
A15	Source T29 Integral_citation
A16	Multiple_sources T29
A107	Certainty_Level T29 L4
T30	Source_cue 1364 1384;1578 1599	Barbara et al (2000) by Kuhn et al (1993).
R20	Cue Arg1:T30 Arg2:T29	
T31	KT_cue 1364 1402	Barbara et al (2000) also demonstrated
R21	Cue Arg1:T31 Arg2:T29	
T32	CL_cue 1364 1402	Barbara et al (2000) also demonstrated
R22	Cue Arg1:T32 Arg2:T29	
T33	Verb_cue 1364 1407	Barbara et al (2000) also demonstrated that
R23	Cue Arg1:T33 Arg2:T29	
T166	Observation 1408 1456	IL-10 deficient mice resulted in severe colitis,
A108	Source T166 Integral_citation
T167	KT_cue 1408 1440	IL-10 deficient mice resulted in
R116	Cue Arg1:T167 Arg2:T166	
T89	Analysis 4035 4097	Another study by Rajasingh et al (2006) also demonstrated that
A53	Verb_noun T89 Certainty
A54	Source T89 Integral_citation
A76	Certainty_Level T89 L4
T90	Source_cue 4035 4074	Another study by Rajasingh et al (2006)
R62	Cue Arg1:T90 Arg2:T89	
T91	KT_cue 4035 4092	Another study by Rajasingh et al (2006) also demonstrated
R63	Cue Arg1:T91 Arg2:T89	
T92	CL_cue 4035 4092	Another study by Rajasingh et al (2006) also demonstrated
R64	Cue Arg1:T92 Arg2:T89	
T168	Verb_cue 4035 4097	Another study by Rajasingh et al (2006) also demonstrated that
R117	Cue Arg1:T168 Arg2:T89	
T169	Observation 4098 4250	IL-10 inhibited inflammation mediated intimal hyperplasia following carotid artery injury in mice by post-transcriptional mRNA destabilisation on TNF-a.
A109	Source T169 Integral_citation
T170	KT_cue 4098 4135	IL-10 inhibited inflammation mediated
R118	Cue Arg1:T170 Arg2:T169	
T116	Analysis 5330 5362	The study also demonstrated that
A71	Source T116 Integral_citation
A72	Verb_noun T116 Certainty
A73	Citation_length T116 Extended
A74	Certainty_Level T116 L4
T117	Source_cue 5330 5339	The study
R81	Cue Arg1:T117 Arg2:T116	
T118	KT_cue 5330 5357	The study also demonstrated
R82	Cue Arg1:T118 Arg2:T116	
T119	CL_cue 5330 5357	The study also demonstrated
R83	Cue Arg1:T119 Arg2:T116	
T171	Verb_cue 5330 5362	The study also demonstrated that
T172	Observation 5363 5465	that rhIL-10 significantly decreased hypertrophy, apoptosis, fibrosis, and preserved cardiac function.
A75	Citation_length T172 Extended
A110	Source T172 Integral_citation
T173	KT_cue 5368 5399	rhIL-10 significantly decreased
R119	Cue Arg1:T173 Arg2:T172	
T36	Analysis 1600 1645	In summary again these results indicated that
A19	Verb_noun T36 Likelihood
A20	Source T36 Hidden
A21	Certainty_Level T36 L2
T37	KT_cue 1617 1640	these results indicated
R25	Cue Arg1:T37 Arg2:T36	
T38	CL_cue 1617 1640	these results indicated
R26	Cue Arg1:T38 Arg2:T36	
T39	Verb_cue 1617 1645	these results indicated that
R27	Cue Arg1:T39 Arg2:T36	
T40	Observation 1646 1776	IL-10 down regulated pro-inflammatory responses such as the Th1 response and emphasised the anti-inflammatory properties of IL-10.
A22	Source T40 Averred
T41	KT_cue 1646 1666	IL-10 down regulated
R28	Cue Arg1:T41 Arg2:T40	
T42	Analysis 1965 2016	Although the studies discussed above indicated that
A23	Verb_noun T42 Likelihood
A25	Source T42 General_reference
A26	Certainty_Level T42 L2
T45	KT_cue 1974 2011	the studies discussed above indicated
R29	Cue Arg1:T45 Arg2:T42	
T49	CL_cue 1974 2011	the studies discussed above indicated
R33	Cue Arg1:T49 Arg2:T42	
T50	Verb_cue 1974 2016	the studies discussed above indicated that
R34	Cue Arg1:T50 Arg2:T42	
T51	Observation 2017 2100	IL-10 administration resulted in the down regulation of pro-inflammatory cytokines,
A27	Source T51 General_reference
T174	KT_cue 2017 2049	IL-10 administration resulted in
R35	Cue Arg1:T174 Arg2:T51	
T46	Analysis 2101 2163	Powrie et al (1993) and Herfarth et al (1996) highlighted that
A28	Verb_noun T46 Speech_act_communication
A29	Source T46 Integral_citation
A30	Certainty_Level T46 L4
T47	Source_cue 2101 2146	Powrie et al (1993) and Herfarth et al (1996)
R31	Cue Arg1:T47 Arg2:T46	
A31	Multiple_sources T46
T48	KT_cue 2101 2158	Powrie et al (1993) and Herfarth et al (1996) highlighted
R32	Cue Arg1:T48 Arg2:T46	
T52	CL_cue 2101 2158	Powrie et al (1993) and Herfarth et al (1996) highlighted
R36	Cue Arg1:T52 Arg2:T46	
T53	Verb_cue 2101 2163	Powrie et al (1993) and Herfarth et al (1996) highlighted that
R37	Cue Arg1:T53 Arg2:T46	
T175	Observation 2164 2338	administration of IL-10 was only successful when administered before the initiation of the inflammatory disease but was ineffective at reversing any established inflammation.
A111	Source T175 Non-integral_information_led_citation
A112	Multiple_sources T175
T176	KT_cue 2164 2191	administration of IL-10 was
R120	Cue Arg1:T176 Arg2:T175	
T64	Analysis 2730 2781	Data from a study by Ma et al (2001) suggested that
A36	Verb_noun T64 Speech_act_communication
A37	Source T64 Integral_citation
A38	Certainty_Level T64 L1
T65	Source_cue 2748 2766	by Ma et al (2001)
R45	Cue Arg1:T65 Arg2:T64	
T66	KT_cue 2730 2776	Data from a study by Ma et al (2001) suggested
R46	Cue Arg1:T66 Arg2:T64	
T67	CL_cue 2730 2776	Data from a study by Ma et al (2001) suggested
R47	Cue Arg1:T67 Arg2:T64	
T68	Verb_cue 2730 2781	Data from a study by Ma et al (2001) suggested that
R48	Cue Arg1:T68 Arg2:T64	
T177	Observation 2782 2911	the p38 mitogen-activated kinase pathway also regulates the human IL-10 promoter via the  activation of sp1 transcription factor.
A113	Source T177 Integral_citation
T178	KT_cue 2782 2837	the p38 mitogen-activated kinase pathway also regulates
R121	Cue Arg1:T178 Arg2:T177	
T130	Analysis 5890 5921	Powrie et al (1993) stated that
A85	Verb_noun T130 Speech_act_communication
A86	Source T130 Integral_citation
A87	Certainty_Level T130 L4
T131	Source_cue 5890 5909	Powrie et al (1993)
R91	Cue Arg1:T131 Arg2:T130	
T132	KT_cue 5890 5916	Powrie et al (1993) stated
R92	Cue Arg1:T132 Arg2:T130	
T133	CL_cue 5890 5916	Powrie et al (1993) stated
R93	Cue Arg1:T133 Arg2:T130	
T134	Verb_cue 5890 5921	Powrie et al (1993) stated that
R94	Cue Arg1:T134 Arg2:T130	
T179	Fact 5922 6144	the administration of systemic IL-10 release is a powerful tool of the central nervous system  and prevents  hyper  inflammatory processes  via  the activation of the neuro-endocrine axis following  acute stress reactions.
A114	Source T179 Integral_citation
T180	KT_cue 5922 5969	the administration of systemic IL-10 release is
R122	Cue Arg1:T180 Arg2:T179	
T86	Observation 3827 4034	which illustrated that the major physiological importance of IL-10 is its ability to limit inflammation, prevent uncontrolled non-adequate immunological reactions and support the humoral Th2 immune response.
A50	Source T86 Integral_citation
A51	Multiple_sources T86
T87	KT_cue 3827 3844	which illustrated
R60	Cue Arg1:T87 Arg2:T86	
T88	Verb_cue 3827 3849	which illustrated that
R61	Cue Arg1:T88 Arg2:T86	
T144	Analysis 6500 6553	For example Hagenbaugh et al (1997) demonstrated that
A52	Verb_noun T144 Certainty
A93	Source T144 Integral_citation
A94	Certainty_Level T144 L4
T181	Verb_cue 6512 6553	Hagenbaugh et al (1997) demonstrated that
R123	Cue Arg1:T181 Arg2:T144	
T145	KT_cue 6512 6548	Hagenbaugh et al (1997) demonstrated
R101	Cue Arg1:T145 Arg2:T144	
T146	CL_cue 6512 6548	Hagenbaugh et al (1997) demonstrated
R102	Cue Arg1:T146 Arg2:T144	
T182	Observation 6554 6664	overexpression of IL-10 in certain tumours such as melanoma and lymphomas promotes the development of tumours.
A115	Source T182 Emphasised
T183	KT_cue 6554 6636	overexpression of IL-10 in certain tumours such as melanoma and lymphomas promotes
R124	Cue Arg1:T183 Arg2:T182	
T147	Analysis 6665 6696	Another study demonstrated that
A95	Verb_noun T147 Certainty
A96	Source T147 Other_citation
A116	Certainty_Level T147 L4
T148	KT_cue 6665 6691	Another study demonstrated
R103	Cue Arg1:T148 Arg2:T147	
T149	CL_cue 6665 6691	Another study demonstrated
R104	Cue Arg1:T149 Arg2:T147	
T150	Verb_cue 6665 6696	Another study demonstrated that
R105	Cue Arg1:T150 Arg2:T147	
T184	Source_cue 6665 6678	Another study
R125	Cue Arg1:T184 Arg2:T147	
T185	Observation 6697 6814	overexpression of IL-10 in cancer patients increased cancer due to the down regulation of the inflammatory cytokines.
A117	Source T185 Hidden
T186	KT_cue 6697 6749	overexpression of IL-10 in cancer patients increased
R126	Cue Arg1:T186 Arg2:T185	
T155	Analysis 6979 7038	One clinical study by Gullestad et al (2001) has shown that
A104	Verb_noun T155 Certainty
A105	Source T155 Integral_citation
A118	Certainty_Level T155 L4
T156	Source_cue 6979 7023	One clinical study by Gullestad et al (2001)
R108	Cue Arg1:T156 Arg2:T155	
T157	KT_cue 6979 7033	One clinical study by Gullestad et al (2001) has shown
R109	Cue Arg1:T157 Arg2:T155	
T158	CL_cue 6979 7033	One clinical study by Gullestad et al (2001) has shown
R110	Cue Arg1:T158 Arg2:T155	
T159	Verb_cue 6979 7038	One clinical study by Gullestad et al (2001) has shown that
R111	Cue Arg1:T159 Arg2:T155	
T187	Observation 7039 7223	chronic heart failure patients treated with intravenous immunoglobulin had an increase in IL-10 which improved left ventricular ejection fraction, although this is not over-expression.
A119	Source T187 Integral_citation
T188	KT_cue 7039 7113	chronic heart failure patients treated with intravenous immunoglobulin had
R127	Cue Arg1:T188 Arg2:T187	
T16	Analysis 753 802	Collectively these findings provide evidence that
A8	Verb_noun T16 Certainty
A9	Source T16 Hidden
A120	Certainty_Level T16 L3
T17	KT_cue 766 797	these findings provide evidence
R11	Cue Arg1:T17 Arg2:T16	
T18	CL_cue 766 797	these findings provide evidence
R12	Cue Arg1:T18 Arg2:T16	
T189	Verb_cue 766 802	these findings provide evidence that
R128	Cue Arg1:T189 Arg2:T16	
T190	Analysis 803 939	IL-10 has the ability to inhibit certain actions of pro-inflammatory cytokines, in some cases by inhibiting their production or release.
A121	Source T190 General_reference
T191	KT_cue 803 827	IL-10 has the ability to
R129	Cue Arg1:T191 Arg2:T190	
A122	Certainty_Level T190 L4
T192	CL_cue 803 827	IL-10 has the ability to
R130	Cue Arg1:T192 Arg2:T190	
T151	Fact 6815 6978	Furthermore whether overexpression of IL-10 directly in the heart would increase disease still remain unknown as little research has been carried out in this area.
A97	Source T151 Averred
T152	KT_cue 6827 6924	whether overexpression of IL-10 directly in the heart would increase disease still remain unknown
R106	Cue Arg1:T152 Arg2:T151	
